| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 490.00K | — |
| Operating expense | — | — |
| Net income | -122.68M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, BEAM returned +78.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +7.4% |
| 1 year | +78.8% |
| 5 years | -73.2% |
| All-time high | $128.71 (Jun 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in BEAM would be worth today ›No. Beam Therapeutics Inc. has not paid a dividend in the past 12 months.
Beam Therapeutics Inc. stock trades on NASDAQ under the ticker symbol BEAM.
Beam Therapeutics Inc. is part of the Healthcare sector.
Beam Therapeutics Inc. has a market cap of 3.07B USD, based on the latest quote.
Beam Therapeutics Inc. is expected to report earnings around Nov 3, 2026. That date is an estimate and has not been confirmed by the company.
